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SUMMARY – Premature infants are susceptible to oxidative stress that causes neonatal disease 
such as retinopathy of prematurity (ROP). Oxidative stress is an imbalance between the production 
of pro-oxidants and the ability of the body to detoxify their harmful eff ects by antioxidants. Th e 
 proliferative phase 2 ROP occurs at around 33rd postmenstrual week (pmw). Th e purpose of our study 
was to evaluate the pro-oxidant/antioxidant status in preterm infants at 33rd pmw. Th e study included 
59 premature infants. ROP was classifi ed according to the International Classifi cation of Retinopathy 
of Prematurity. Total oxidative status (TOS), total antioxidant status (TAS), malondialdehyde (MDA) 
and paraoxonase 1 (PON1) activity were determined spectrophotometrically. Th e values of the pro-
oxidants TOS and MDA were signifi cantly higher in infants with ROP as compared to infants 
without ROP (p<0.05 both). Th ere were no signifi cant diff erences in the values of TAS and PON1 
between the infants with and without ROP. According to study results, TOS and MDA are good 
markers of oxidative stress, whereas TAS and PON1 activity are unreliable in assessing antioxidant 
protection.
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Introduction
Premature infants belong to the category of ‘vul-
nerable newborns’ because of the large proportion of 
total perinatal morbidity and mortality. Th ey are espe-
cially susceptible to oxidative stress, which aff ects a 
variety of organs, often simultaneously, causing neona-
tal diseases such as retinopathy of prematurity (ROP), 
bronchopulmonary dysplasia, necrotizing enterocoli-
tis, intraventricular hemorrhage, periventricular leuko-
malacia, respiratory distress syndrome, intrauterine 
growth retardation and congenital malformation. Th ese 
diseases have also been reported to be oxidative stress-
related neonatal diseases1,2.
Retinopathy of prematurity (ROP) is the most im-
portant disease of prematurity and a major cause of 
blindness in children. ROP continues to be the leading 
cause of lifelong visual impairment among children in 
developed countries3. ROP occurs in two phases. Th e 
ischemic phase 1 begins after premature birth with de-
layed retinal vascular growth. Th e proliferative phase 2, 
characterized by pathologic neovascularization, occurs 
around 33rd postmenstrual week (pmw)4-8.
Oxidative stress is imbalance between the produc-
tion of pro-oxidants and the ability of the body to de-
toxify their harmful eff ects through neutralization by 
antioxidants. Th e process of birth itself is an oxidative 
challenge for the newborn. Sharp postnatal transition 
from intrauterine environment with a relatively low 
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oxygen content into an environment with signifi cantly 
higher oxygen content exposes the infant to oxidative 
stress, which is emphasized in premature infants due 
to low effi  ciency of antioxidant protection9. In prema-
ture infants, autoregulation of the blood network of 
retina is adequate in a narrow range of perfusion pres-
sure. Th e absence of autoregulation leads to hyperoxia 
of retina10. Disturbance in the equilibrium of pro-oxi-
dants and antioxidants initiates an infl ammatory 
 process in retinal tissue leading to development of 
ROP11,12.
Free radicals are reactive and short-lived species so 
that direct measurement is usually not possible. How-
ever, hundreds of reactive oxygen species are known to 
be derived from the interaction of free radicals with 
biomolecules1.
Alternatively to measurements of oxidation prod-
ucts, a test measuring total oxidative status (TOS) was 
recently developed13. Malondialdehyde (MDA) is the 
end product of lipid peroxidation and a good marker 
of oxidative stress. Th is aldehyde is a highly toxic mol-
ecule. Its interaction with DNA and proteins has often 
been referred to as potentially mutagenic and athero-
genic12,14,15.
Total antioxidant status (TAS) is not just a simple 
sum of the individual activities of antioxidant sub-
stances. It is actually a dynamic system of interdepen-
dent individual serum antioxidant parameters. TAS 
assay has been designed to determine the overall anti-
oxidant power of samples contributed by antioxidants 
and their interactions. Evaluation of TAS in body fl uid 
has been used as one of the biological markers for 
monitoring oxidative stress in humans16.
Paraoxonase (PON) is a Ca2+-dependent enzyme 
that is synthesized in the liver and is found in various 
tissues and plasma. Th e enzyme takes place in the 
structure of high-density lipoprotein (HDL) in plas-
ma17. PON1 has antioxidant property because it pre-
vents the increase of reactive oxygen species quantity 
by hydrolyzing lipid peroxidation products. It also pro-
tects cell from damage caused by oxidative stress18. 
PON family members were upregulated in late-gesta-
tion human fetuses and are a candidate therapeutic in 
premature human infants19.
Studies have confi rmed that oxidative stress leads 
to tissue damage during pregnancy, and clinical prac-
tice has confi rmed that the application of antioxidants 
can prevent and reduce the diseases caused by oxida-
tive stress20-22.
Th e purpose of our study was to evaluate and com-
pare the pro-oxidant/antioxidant status in preterm in-
fants (with and without ROP) at 33rd pmw (the begin-
ning of phase 2 ROP) by measuring the TOS, MDA, 
TAS and PON1 activity.
Materials and Methods
Study design and patients
Th e study (cohort, prospective) was conducted in 
the Department of Neonatology, Clinical Centre of 
Montenegro, Podgorica, with parental informed writ-
ten consent and after institutional ethical clearance. 
Th e study included 59 premature infants, gestational 
age (GA) of 33 weeks or less. Venous blood sample 
was obtained from every infant included in the study 
in the 33rd pmw. All parameters were determined at 
33rd pmw. Preterm neonates with gross congenital ab-
normalities were excluded from the study.
Screening for ROP was done by indirect ophthal-
moscopy. ROP was classifi ed according to the Interna-
tional Classifi cation (ICROP) and subdivided into 5 
stages. Proliferative ROP (ROP+) was defi ned as stage 
3, stage 4 or stage 5. Th ese infants required treatment 
for ROP (laser therapy or anti-VEGF treatment). In-
fants with correct ophthalmologic fi ndings and mod-
erate ROP (stage 1 and stage 2) were defi ned as in-
fants without ROP (ROP-).
Ethics Committee of the Clinical Centre of Mon-
tenegro in Podgorica approved the study protocol 
(consent number 03/01-3813/4), in accordance with 
standard procedures of the Ethics Committee of the 
Clinical Center of Montenegro and international 
guidelines for the performance of biomedical research 
on humans.
Measurement of pro-oxidant markers
Since the measurement of diff erent oxidant mole-
cules separately is not practical, TOS of a sample was 
measured. We used Erel’s colorimetric method for 
measuring TOS. Th e assay is based on the oxidation of 
ferrous ion to ferric ion. Color intensity, which can be 
measured spectrophotometrically, is related to the total 
amount of oxidant molecules present in the sample. 
Th e assay is calibrated with hydrogen peroxide (H2O2) 
and the results were expressed in terms of micromolar 
hydrogen peroxide equivalent per liter (μmol H2O2 
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Eq/L)13. MDA was determined as a thiobarbituric 
acid-reacting substance (TBARS) spectrophotometri-
cally. Th iobarbituric acid (TBA) is widely used to mea-
sure TBARS of lipid oxidation. TBA reacts with 
MDA, a product of lipid oxidation, to give a red, fl uo-
rescent MDA/TBA adducts with maximum absor-
bance at 532 nm. Th e results are expressed in μmol/L15.
Measurement of antioxidant markers
Total antioxidant status assays have been designed 
to determine overall antioxidant power of samples. 
TAS was determined by a modifi ed Erel’s method, i.e. 
a colorimetric test which depends on the production of 
hydroxyl radical. Th e results are expressed in mmol/L23.
We used the principle of spectrophotometric de-
termination of PON1 activity by using paraoxon as 
substrate. Th e sample is mixed with a substrate dis-
solved in a buff er solution, and the product generated 
by hydrolysis of the substrate is monitored for a certain 
time at a linear rate and defi ned temperature. Th e re-
sults are expressed in U/L24.
Statistical analysis
Data were presented as mean ± standard deviation 
(SD). Kolmogorov-Smirnov test was used to verify the 
normality of distribution of parameters. In order to 
analyze statistically signifi cant diff erences in the mean 
values of the examined parameters between the groups, 
Student’s t test was used according to data distribu-
tion. Th e existence of statistically signifi cant correla-
tions between variables was confi rmed using the 
Spearman nonparametric correlation. A p-value of less 
than 0.05 was considered statistically signifi cant.
Results
Overall, 59 patients were included in the study. 
ROP was diagnosed in 18 (30.5%) infants, whereas in 
41 (69.5%) infants ophthalmologic fi ndings were cor-
rect or they had moderate ROP.
Th e mean gestational age (GA) and birth weight 
(BW) of preterm infants with and without ROP are 
displayed in Table 1. Student’s t-test showed signifi -
cant diff erence in GA and BW between infants with 
and without ROP. Premature infants with ROP had a 
signifi cantly shorter mean GA (p<0.01) and lower 
mean BW (p<0.05).
Th e mean length of mechanical ventilation for in-
fants with ROP was 14.1±1.31 days. Th e mean length 
of mechanical ventilation for infants without ROP 
was 6.1±0.54 days (Fig. 1). Student’s t-test showed a 
statistically signifi cant diff erence in the length of ven-
tilation for infants with and without ROP. Premature 
infants with ROP were ventilated signifi cantly longer 
(p<0.05).
Th e values of the pro-oxidant and antioxidant 
markers are presented in Table 2. TOS and MDA val-
ues in premature infants with ROP were TOS 
60.6±4.88 μmol/L and MDA 1.82 (1.38 to 2.40) 
μmol/L. In premature infants without ROP, the pro-
oxidant markers were lower: TOS 38.6±3.17 μmol/L 
and MDA 1.33 (1.16 to 1.52) μmol/L. For both pa-
rameters, the diff erence was statistically signifi cant 
(p<0.05).
Premature infants that developed ROP had lower 
values of TAS (1.1±0.64 mmol/L) than infants with-
out ROP (1.2±0.69 mmol/L). PON1 activity was 
higher in infants with ROP (89.6±13.0 U/L) than in 
Table 1. Mean gestational age and birth weight 
of premature infants with and without retinopathy 
of prematurity (ROP)
Parameter ROP+ (n=18)
ROP- 
(n=41) p
Gestational age 
(weeks) 30.6±2.1 31.8±1.4 p<0.01*
Birth weight (g) 1587±418 1822±370 p<0.05*
Data are expressed as mean ± standard deviation; continuous vari-
ables were compared using Student’s t-test; *statistically signifi cant 
values
Fig. 1. Length of ventilation in premature infants with 
and without retinopathy of prematurity (ROP).
*p<0.05 ROP+ vs. ROP-
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those without ROP (60.3±7.24 U/L). Th ere was no 
signifi cant diff erence between the groups (p=0.55; 
p=0.15).
Spearman’s nonparametric correlation showed sig-
nifi cant positive correlation between TAS values and 
GA, and between TAS and BW (Table 3). We also 
found signifi cant positive correlation between PON1 
activity and MDA (Table 3).
Discussion and Conclusion
Newborns, especially premature ones, are at an in-
creased risk of damage mediated by oxidative stress. In 
the present study, we investigated parameters of oxida-
tive stress (pro-oxidants and antioxidants) in prema-
ture infants at 33rd pmw (onset of ROP 2 phase) in 
order to understand the signifi cance of these parame-
ters in the pathogenesis of ROP.
Pro-oxidants were assessed by measuring TOS and 
serum MDA. Antioxidant protection was estimated by 
measuring TAS and PON1 activity. Nowadays, these 
markers can be measured by simple and sensitive 
methods.
All infants included in the study (N=59) were 
screened for ROP. Timing of the fi rst ROP screening 
examination was also at 33rd pmw. Laser photocoagu-
lation was used in 18 (30.5%) infants.
According to our results, premature infants with 
ROP had a signifi cantly lower BW, shorter GA (Table 
1) and longer duration of mechanical ventilation (pro-
longed oxygen exposure) (Fig. 1).
Studies also confi rmed strong connection between 
short GA, low BW, mechanical ventilation and ROP. 
It has been reported that premature infants on pro-
longed ventilation have more chances for development 
of ROP12,25,26.
We found a statistically signifi cant diff erence in 
TOS values between infants with and without ROP. 
Infants with ROP had signifi cantly higher values of 
TOS (Table 2).
Studies confi rm that vasoconstriction in the retina 
is an early response to oxygen that can lead to vaso-
obliteration, neovascularization, and retinal traction 
(ROP). Disturbance in the equilibrium of oxidant and 
antioxidant status initiates an infl ammatory process in 
retinal tissue leading to development of ROP12,27.
As shown in Table 2, MDA was also signifi cantly 
higher in infants with ROP. According to our results, 
serum concentration of MDA is a good marker of oxi-
dative stress and a ROP predictor.
Studies have shown that elevated levels of serum 
MDA were associated with adverse respiratory and 
ophthalmologic outcome in very-low-birth-weight in-
fants14. Infants exposed to higher oxidative stress (pre-
mature infants, newborns from cesarean section) have 
a higher level of MDA28,29. Also, signifi cant oxidative 
stress can be easily assessed by measuring urinary 
MDA levels30. Th e concentrations of MDA were not 
predictors of bronchopulmonary dysplasia/death31.
In the present study, we did not fi nd a statistically 
signifi cant diff erence in TAS values and PON1 activ-
ity between the groups. TAS values were lower in in-
fants with ROP, while the values of PON1 activity 
were even higher in infants with ROP (Table 2).
Studies confi rm that inadequate TAS is associated 
with development of various pathologic conditions in-
cluding hypoxic injury and ROP32. Decreased mater-
nal serum PON1 levels may also have a role in preterm 
Table 3. Correlation among antioxidative parameters 
and gestational age, body weight and malondialdehyde 
(oxidative stress marker)
Parameter TAS (μmol/L)
PON1 
(U/L)
Gestational age (weeks)
Birth weight (g)
Malondialdehyde (μmol/L)
+0.42*
+0.55*
/
/
/
+0.292**
Spearman’s coeffi  cient ρ; TAS = total oxidative status; PON1 = 
paraoxonase 1 activity; *p<0.05; **p<0.001
Table 2. Pro-oxidant and antioxidant parameters 
in patients with and without retinopathy of prematurity 
(ROP)
Parameter ROP+ (n=18)
ROP- 
(n=41) p
TOS (μmol/L) 60.6±4.88 38.6±3.17 p<0.05
MDA (μmol/L)* 1.82 (1.32-2.40)
1.33 
(1.16-1.52) p<0.05
TAS (mmol/L) 1.1±0.64 1.2±0.69 p=0.55
PON1 (U/L) 89.6±13.01 60.3±7.24 p=0.15
TOS = total oxidant status; MDA = malondialdehyde; TAS = total 
antioxidant status; PON1 = paraoxonase 1; data expressed as mean 
± standard deviation; *data expressed as median values (interquar-
tile range); continuous variables were compared using Student’s 
t test
Lidija Banjac et al. Pro-oxidants and antioxidants in retinopathy of prematurity
462 Acta Clin Croat, Vol. 57, No. 3, 2018
birth33. Th ere are a limited number of studies on pre-
term infants, which evaluated PON1 levels, especially 
in infants with ROP.
Our results showed positive correlation between 
MDA and PON1 (Table 3), which made us think of 
the possible compensatory increase in PON1 as a pro-
tective factor. PON1 plays an important role as an an-
tioxidant in preventing oxidation of low-density lipo-
proteins34.
Our study showed the level of oxidants to correlate 
signifi cantly with the development of ROP. Our re-
sults did not confi rm statistically signifi cant between-
group diff erence in the level of antioxidants. We sup-
pose that the reason for the increased levels of antioxi-
dants at 33rd pmw in infants with ROP was in response 
to oxidative stress.
According to our results, TOS and MDA are good 
markers of oxidative stress, while TAS and PON1 ac-
tivity are unreliable in assessing antioxidant protection.
Additional research in this area should contribute 
to better understanding the pathogenesis of ROP, as 
well as to development of more eff ective preventive 
and therapeutic procedures.
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Sažetak
PRO-OKSIDANSI I ANTIOKSIDANSI U PREMATURNOJ RETINOPATIJI
L. Banjac, G. Banjac, J. Kotur-Stevuljević, V. Spasojević-Kalimanovska, T. Gojković, 
N. Bogavac-Stanojević, Z. Jelić-Ivanović i G. Banjac
Nedonoščad je osobito osjetljiva na oksidacijski stres koji uzrokuje bolesti poput prematurne retinopatije (PR). Oksida-
cijski stres je neravnoteža između proizvodnje pro-oksidansa i sposobnosti tijela za detoksikaciju njihovih štetnih učinaka 
antioksidansima. Druga, proliferacijska faza PR započinje oko 33. postmenstrualnog tjedna (pmt). Svrha našega istraživanja 
bila je procijeniti pro-oksidacijski/antioksidacijski status u nedonoščadi u 33. pmt. U istraživanju je sudjelovalo 59 nedo-
noščadi. PR je klasifi cirana prema Međunarodnoj klasifi kaciji PR. Totalni oksidacijski status (TOS), totalni antioksidacijski 
status (TAS), malondialdehid (MDA) i paraoksonaza 1 (PON1) određeni su spektrofotometrijski. Vrijednosti pro-oksi dansa 
TOS i MDA u nedonoščadi s PR bile su značajno više nego u nedonoščadi bez PR (p<0,05 za oba). Nije bilo značajne  razlike 
u vrijednostima TAS i PON1 između nedonoščadi s PR i bez PR. Naše istraživanje je pokazalo da razina pro-oksidansa 
značajno korelira s razvojem PR, ali nije potvrdilo značajnu razliku u razini antioksidansa između skupina. Prema našim 
rezultatima TOS i MDA dobri su pokazatelji oksidacijskog stresa, dok su TAS i PON1 nepouzdani u procjeni antioksidacij-
ske zaštite.
Ključne riječi: Reaktivni spojevi kisika; Antioksidansi; Retinopatija nedonoščadi; Nedonošče; Oksidacijski stres
